Abiopharma

🔍 Khetani Mansi (Executive)

Company: ChargePoint Holdings, Inc. (CHPT)

Report Date: 2026-03-23

Detailed Transactions and Holdings:

• Sold 2,311 shares of Common Stock at $5.3 per share (Direct)
  Date: 2026-03-23 | Code: S | equity_swap_involved: 0 | shares_owned_after: 128,500.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
• F2: Includes 448 shares acquired under the Issuer's Employee Stock Purchase Plan on March 9, 2026, in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).